This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Abbvie Deutschland Gmbh and Co Kg. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Dietrich Granzow: Innovator in Pharmaceutical Formulations
Introduction
Dietrich Granzow is a notable inventor based in Ludwigshafen, Germany. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of solid retard formulations.
Latest Patents
Granzow holds a patent for "Solid retard formulations based on solid dispersions." This formulation comprises a melt-processed solid dispersion product that includes an active agent, a pharmaceutically acceptable thermoplastic polymer of N-vinyl lactams, and a pharmaceutically acceptable polyvinyl alcohol-polyalkylene glycol graft copolymer. The patent also details a method for producing this formulation.
Career Highlights
Dietrich Granzow is associated with AbbVie Deutschland GmbH & Co. KG, where he has been instrumental in advancing pharmaceutical technologies. His work focuses on improving drug delivery systems and enhancing the efficacy of therapeutic agents.
Collaborations
Some of his notable coworkers include Gunther Berndl and Juergen Weis, who have collaborated with him on various projects within the pharmaceutical sector.
Conclusion
Dietrich Granzow's innovative work in solid retard formulations exemplifies the importance of research and development in the pharmaceutical industry. His contributions continue to influence the field and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile